Gregory Knutson - Feb 24, 2022 Form 4 Insider Report for U.S. Stem Cell, Inc. (USRM)

Role
Director
Signature
/s/ Gregory Knutson
Stock symbol
USRM
Transactions as of
Feb 24, 2022
Transactions value $
$1,250,000,000,000
Form type
4
Date filed
3/4/2022, 03:01 PM
Previous filing
Jul 23, 2021
Next filing
Mar 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding USRM Common Stock 1.68M Feb 24, 2022 Direct
holding USRM Common Stock 38M Feb 24, 2022 Held by NorthStar Biotech Group, LLC of which Gregory Knutson is Managing Director

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction USRM Convertible promissory Note (right to buy) Award $1.25T +12.5M +344.83% $100,000.00* 16.1M Feb 24, 2022 Common Stock 12.5M $0.01 Direct F1
transaction USRM Warrant Award +12.5M +77.52% 28.6M Feb 24, 2022 Common Stock 12.5M $0.01 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Previously reported; By addendum the conversion price was adjusted and the maturity date extended.
F2 Issued in consideration of the extension of the extension of the maturity date.